Cytokinetics Incorporated logo

Cytokinetics Incorporated

Sector: 
Healthcare
   

Industry: 
Biotechnology

50.81
 
USD
  
-0.02
  
(-0.04%)
Optionable: Yes  Market Cap: 4,783 M  90-day average vol: 1,419,116

Previous close: 50.83  Open: 50.85  Bid: 52.5  Ask: 52.5
52 week range    
29.10   
   54.74
Peers   
ABIO / 
LGND / 
ACOR / 
TRVN / 
AMGN / 
Last updated: Wednesday 17th August 2022
43
MarketXLS Rank marketxls
40
Value marketxls
53
Technical marketxls
36
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABIO

0 B-1.21.94

ACOR

0 B-0.11.91

AMGN

0.0347129 B23.4223.53

ARRY

2 B-38.79.53

LGND

2 B31.2124.04

TRVN

0 B-1.80.5074
Chart
News
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: -1.347


Financials

CYTK Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues8 M31 M47 M29 M106 M13 M32 M27 M56 M70 M
Cost of sales-591000-433000-490000-589000-741000-2 M-1 M-1 M95 M158 M
Gross operating profit8 M31 M47 M29 M106 M13 M32 M27 M-41 M-90 M
Selling Gen & administrative expense12 M15 M17 M20 M28 M36 M31 M40 M53 M97 M
Research & development expense36 M49 M44 M46 M60 M90 M89 M86 M97 M160 M
Operating income-41 M-34 M-15 M-37 M19 M-113 M-89 M-99 M-94 M-186 M
floaterest income0000000000
floaterest expense0000000000
Other income net560000000000-1840000
Pre-tax Income (EBT)-40 M-34 M-15 M-38 M16 M-128 M-106 M-122 M-127 M-215 M
Income taxes0000000000
Net income from total operations-40 M-34 M-15 M-38 M16 M-128 M-106 M-122 M-127 M-215 M
Minority floaterest0000000000
Total net income-40 M-34 M-15 M-38 M16 M-128 M-106 M-122 M-127 M-215 M
Preferred dividends1 MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-42 M-34 M-15 M-38 M16 M-128 M-106 M-122 M-127 M-215 M
Depreciation5910004330004900005890007410002 M1 M1 M2 M2 M
Amortization0000000000
Operating income before depreciation (EBITDA)-40 M-33 M-14 M-37 M20 M-109 M-83 M-93 M-87 M-184 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-2.28-1.24-0.41-0.970.41-2.59-1.95-2.11-1.97-2.8
Diluted EPS total-2.28-1.24-0.41-0.970.39-2.59-1.95-2.11-1.97-2.8
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!